Functional analysis of the fibrinogen Aα Thr312Ala polymorphism: Effects on fibrin structure and function

Circulation

Volumn 107, Issue 18, 2003, Pages 2326-2330

  Standeven, Kristina F ^a   Grant, Peter J ^a,c   Carter, Angela M ^a   Scheiner, Thomas ^b   Weisel, John W ^b   Ariëns, Robert A S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Fibrin; Fibrinogen; Thrombosis

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRINOGEN; FIBRINOGEN AALPHA; FIBRINOGEN VARIANT; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CROSS LINKING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; MORTALITY; PRIORITY JOURNAL; STROKE; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS;

BLOOD COAGULATION; ELASTICITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR XIIIA; FIBRIN; FIBRINOGEN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0037986620     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000066690.89407.CE     Document Type: Article

References (18)

1. Muszbek L, Adany R, Mikkola H, Novel aspects of blood coagulation factor XIII, IL structure, distribution, activation, and function. Crit Rev Clin Lab Sci. 1996;33:357-421.
2. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448. Blood. 1993;82:2117-2124.
3. Kimura S, Aoki N. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. J Biol Chem. 1986;261:15591-15595.
4. Credo RB, Curtis CG, Lorand L. Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa): calcium ion regulatory aspects. Biochemistry. 1981;20:3770-3778.
5. Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci. 2001;936:312-327.
6. Carter AM, Catto AJ, Grant PJ. The association of the α-fibrinogen Thr312Ala polymorphism with post-stroke mortality in subjects with atrial fibrillation. Circulation. 2001;99:2423-2426.
7. Carter AM, Catto AJ, Kohler HP, et al. Alpha fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood. 2000;96:1177-1179.
8. Takebe M, Soe G, Kohno I, et al. Calcium ion-dependent monoclonal antibody against human fibrinogen: preparation, characterization, and application to fibrinogen purification. Thromb Haemost. 1995;73:662-667.
9. Ariëns RA, Philippou H, Nagaswami C, et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96:988-995.
10. Woodhead JL. Nagaswami C. Matsuda M, et al. The ultrastructure of fibrinogen Caracas II molecules, fibers and clots. J Biol Chem. 1996;271:4946-4953.
11. Standeven KF, Ariëns RA, Whitaker P, et al. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002;51:189-197.
12. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
13. Blombäck B, Carlsson K, Hessel B, et al. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
14. Fatah K, Silveira A, Tornvall P, et al. Proneness to formation of tight, and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost. 1996;76:535-540.
15. Fatah K, Hamsten A, Blomback B, et al. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost. 1992;68:130-135.
16. Mills JD, Ariëns RA, Mansfield MW, et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002;106:1938-1942.
17. Ryan EA, Mockros LF, Weisel JW, et al. Structural origins of fibrin clot rheology. Biophys J. 1999;77:2813-2826.
18. Curran JM, Fatah-Ardalani K, Tornvall P, et al. A hypothesis to explain the reported association of the alpha-fibrinogen A312 allele with thromboembolic disease. Thromb Haemost. 2001;85:1022-1023.